[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337185-105":59,"doc-detail-337185-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-implications-of-occult-nodal-metastases-in-patients-with-clinically-n0-primary-parotid-gland-cancer","Prognostic Implications of Occult Nodal Metastases in Patients with Clinically N0 Primary Parotid Gland Cancer","","Background and objectives: The prognostic role of occult nodal metastases in clinically N0 primary parotid gland cancer remains unclear. Such metastases are histologically diverse and may show unpredictable clinical courses. This study evaluated prognostic utilities of occult metastases, including metastases in intraparenchymal lymph nodes (PARs), focusing particularly on pathological T (pT) classification. Materials and methods: Retrospective review of surgical cases from 2000–2022; primary outcomes were 5-year OS and 5-year DFS.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-implications-of-occult-nodal-metastases-in-patients-with-clinically-n0-primary-parotid-gland-cancer/337185/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-implications-of-occult-nodal-metastases-in-patients-with-clinically-n0-primary-parotid-gland-cancer/337185.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of evaluating occult nodal metastases in clinically N0 primary parotid gland cancer?","Question",{"text":112,"@type":113},"To clarify the prognostic value of occult nodal metastases, especially metastases in intraparenchymal lymph nodes (PARs), and how they relate to pathological T (pT) classification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic outcomes measured in this retrospective study?",{"text":117,"@type":113},"The study used 5-year overall survival (OS) and 5-year disease-free survival (DFS) as primary outcome variables.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about PAR metastases and 5-year DFS?",{"text":121,"@type":113},"PAR metastases significantly reduced 5-year DFS in patients with early pT1/2 status, while this effect was not significant in advanced pT3/4 cases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337185,1790142286,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Article  \nPrognostic Implications of Occult Nodal Metastases in Patients with Clinically N0 Primary Parotid Gland Cancer  \nJooin Bang 1, Oh-Hyeong Lee 2, Geun-Jeon Kim 2, Dong-Il Sun 2 and Sang-Yeon Kim 2, *  \nCitation: Bang, J.; Lee, O.-H.; Kim, G.-J.; Sun, D.-I.; Kim, S.-Y. Prognostic Implications of Occult Nodal Metastases in Patients with Clinically N0 Primary Parotid Gland Cancer. Medicina 2024, 60, 1942. [https://](https://)[ ](https://)[doi.org/10.3390/medicina60121942](doi.org/10.3390/medicina60121942)  \n[Academic Editor: Mario P](Academic Editor: Mario P)érezSayáns  \nReceived: 4 November 2024  \nRevised: 14 November 2024  \nAccepted: 18 November 2024  \nPublished: 25 November 2024  \nCopyright: © 2024 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Otolaryngology-Head and Neck Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea; [worldji@hanmail.net](worldji@hanmail.net)  \n[2](2 Department of Otolaryngology-Head and Neck Surgery)[ Department of Otolaryngology-Head and Neck Surgery](2 Department of Otolaryngology-Head and Neck Surgery), [Seoul St](Seoul St). Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea; [zzangyoh@gmail.com](zzangyoh@gmail.com) (O.-H.L.); [emelenciana@naver.com](emelenciana@naver.com) (G.-J.K.); [hnsdi@catholic.ac.kr](hnsdi@catholic.ac.kr) (D.-I.S.)  \n* Correspondence: [ksyent@catholic.ac.kr](ksyent@catholic.ac.kr)  \nAbstract: Background and Objectives: The role of occult nodal metastases in patients with parotid gland cancers remains unclear; such metastases are histologically diverse and exhibit unpredictable clinical courses. Here, we evaluated the prognostic utilities of such metastases, including metastases in the intraparenchymal lymph nodes (PARs) . Materials and Methods: We retrospectively reviewed the medical charts of patients who underwent surgery to treat clinically N0 primary parotid gland cancers from 2000 to 2022 . The primary outcome variables were 5-year overall survival (OS) and 5-year disease-free survival (DFS) . We explored the effects of occult nodal metastases, including metastases in the PARs, especially in terms of the pathological T (pT) classification. Results: Among 74 patients, 48 (64.8%) were pT1/2 cases, and 26 (35.2%) were pT3/4 cases. Both perineural and lymphatic invasion were negatively associated with the 5-year DFS (hazard ratio [HR] = 3.533, 95% confidence interval [CI] = 1.325–9.421, p = 0.012; HR = 4.028, 95% CI = 1.497–10.839, p = 0.006, respectively) . During pathological review, PAR metastases were observed in 12 patients (16.2%), and other occult metastases were present in 8 patients (10.8%) . PAR metastases reduced the 5-year DFS in pT1/2 cases (87.2% vs. 22.2%, p = 0.001) but not in pT3/4 cases. Conclusions: PAR metastases significantly reduced the 5-year DFS in patients with clinically N0 primary parotid gland cancer. On subgroup analysis according to pT classification, this effect was significant among patients with early pT1/2 status but not patients with advanced pT3/4 status.  \nKeywords: parotid neoplasm; lymphatic metastasis; lymph nodes; prognosis; disease-free survival  \n1. Introduction  \nSalivary gland cancers are relatively rare, constituting 1% to 3% of all head-and-neck cancers. However, such cancers pose significant challenges to otolaryngologists because their incidence has increased over the past several decades [1] . The histopathological subtypes of these cancers are diverse, their clinical behaviors are unpredictable, and their outcomes are variable. It is","cbCaikaIV12IPDz6","https://ap.wps.com/l/cbCaikaIV12IPDz6","pdf",1074109,11,"English","# Abstract\n## Background and Objectives\n## Materials and Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and Prognostic Challenges\n## Lymph Node Metastasis and PARs\n## Study Rationale and Controversies","[{\"question\":\"What was the main purpose of evaluating occult nodal metastases in clinically N0 primary parotid gland cancer?\",\"answer\":\"To clarify the prognostic value of occult nodal metastases, especially metastases in intraparenchymal lymph nodes (PARs), and how they relate to pathological T (pT) classification.\"},{\"question\":\"How were prognostic outcomes measured in this retrospective study?\",\"answer\":\"The study used 5-year overall survival (OS) and 5-year disease-free survival (DFS) as primary outcome variables.\"},{\"question\":\"What did the study find about PAR metastases and 5-year DFS?\",\"answer\":\"PAR metastases significantly reduced 5-year DFS in patients with early pT1/2 status, while this effect was not significant in advanced pT3/4 cases.\"}]","Prognostic Implications of Occult Nodal Metastases in Patients with Clinically N0 Primary Parotid Gland Cancer | PDF",1790018049,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e702d6d4962e9d5861614169d5b441f3.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69752fa84790145af5fc039de865d76d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e338bdff0feece65b44e4174aa34e394.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a16d80569d0f8a9cfc3cd91dd10f603.webp",980,1385]